Simultaneous LCMSMS Method for Doxorubicin, Doxorubicinol, and Cyclophosphamide
Analyte
Lower Limit of Quantitation
(mg/L)
Acceptable Anticoagulants
Required PlasmaVolume
CV% low QC
Doxorubicin
0.00304
Heparinized Plasma (Na)
Minimal 1 mL*
5
Doxorubicinol
0.0072
5
Cyclophosphamide
0.44
10
Samples are prepared by solid phase extraction prior to chromatography. Internal standards are added to 0.4 mL of sample mixed with HCL solution prior to application onto a preconditioned Waters Oasis� HLB cartridge. The cartridge is rinsed with 5% methanol in HPLC grade water. The samples are then eluted with methanol and evaporated to dryness. The samples are reconstituted with a 75:25 mix of mobile phase A and acetonitrile, respectively. Twenty percent of the reconstituted samples are injected in the LCMSMS system.
Samples are analyzed on a Agilent HPLC system coupled to a Sciex API3000 triple quadupole mass analyzer used in the positive MRM mode. A gradient chromatography method separates the compounds from other components on a Waters Symmetry� C18 column. Each sample analysis requires 11 minutes.